Sexuality – Lifestyle
Author:
Genmab A/S
Major Shareholder Announcement
May 8, 2026
Genmab Announces Financial Results for the First Quarter of 2026
May 7, 2026
Major Shareholder Announcement
April 14, 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
April 14, 2026
Major Shareholder Announcement
April 1, 2026
Major Shareholder Announcement
March 30, 2026